Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Chardan Capital Markets Downgrades iPass Inc. (IPAS) to Neutral
-
Chardan Capital Markets Downgrades The KEYW Holding Corporation (KEYW) to Neutral
-
Chardan Capital Markets Starts Avalanche Biotechnologies (AAVL) at Neutral
-
Chardan Capital Markets Starts POZEN Inc. (POZN) at Buy, $10 PT
-
Chardan Capital Markets Starts Ophthotech Corp (OPHT) at Buy
-
Signal Genetics (SGNL) Prices 3.2M Common Offering at $2.80/Share
-
Signal Genetics Prices $9,000,000 Public Offering
-
Chardan Capital Markets Upgrades Himax Technologies (HIMX) to Neutral
-
Chardan Sees Himax (HIMX) Q4 Results Flat with Pre-Announcement; Guide-Down for Q1 Expected
-
Chardan Capital Markets Starts Ohr Pharmaceutical (OHRP) at Buy, Sees 166% Upside
-
Chardan Bullish on Globalstar (GSAT) Following FCC AWS-3 Auction Results
-
Pre-Open Stock Movers 01/26: (OCN) (OLED) (RGP) (MWV) Higher; (MAT) (STX) (PRE) (Lower (more...)
-
Chardan Capital Markets Assumes Coverage on StemCells (STEM) at Buy
-
Chardan Cuts Price Target, Ests on Profire Energy (PFIE) Amid Falling Energy Prices
-
Tower Semiconductor (TSEM) PT Raised to $17 at Chardan Capital Markets
-
Chardan Affirms Himax (HIMX) at 'Sell'; Google Stops Production of Current Google Glass Version
-
Chardan Capital Markets Starts Integrated Device Technology (IDTI) at Buy; The Next Killer App
-
Chardan Capital Markets Notes 'Highly Bullish' Development for Penny Stock Ener-Core (ENCR)
-
PlacementTracker Publishes 2014 PIPE Market League Tables
-
Notable Analyst Rating Changes 12/31: (MIG) (PERI) Downgraded
-
Chardan Capital Downgrades Perion Network (PERI) to Neutral; Changes at Google Not Fully Reflected
-
Chardan Capital Drops Coverage on MagnaChip (MX)
-
GoPro (GPRO) Follows Ambarella (AMBA) Lower as Another Sell-Side Analyst Turns Negative
-
Check-Cap Ltd. (CHEK) Files $15.75M IPO
-
Document Security Systems (DSS) Plans Common Stock Offering
-
Chardan Capital Markets Starts Ener-Core (ENCR) at Buy
-
Streetinsider.com's Hot Lunchtime Reads 12/10: (TSLA) (TWTR) (FB) (HRB) (MSFT)
-
Chardan Capital Bumps PT on IDT (IDT) to $18; Money Remittance Business Remains Key Growth Driver
-
Weak Smartphone Demand Could Put Himax (HIMX) Q4 Consensus at Risk - Chardan Capital Markets
-
Chardan Capital Markets Starts Vuzix Corp. (VUZI) at Buy, $6 PT on Smart Glass Opportunity
-
Chardan Capital Markets Downgrades Ambarella (AMBA) to Sell
-
Chardan Capital Bullishness on 22nd Century (XXII) Reaffirmed Following Management Conf. Call
-
Chardan Positive on Globalstar (GSAT) Following FCC AWS-3 Auction; Maintains 'Buy' Rating
-
Rockwell Medical Technologies (RMTI) Prices 6.5M Shares at $9/Share
-
Myos Corp. (MYOS) Announces $1.8M Registered Direct Offering
-
Rockwell Medical Technologies (RMTI) to Offer $55M in Common Stock
-
Chardan Capital Remains 'Cautiously Optimistic' on YOU On Demand (YOD); Cuts PT to $8 Following Q3 Results
-
Himax (HIMX) Remains Sell-Rated at Chardan; Focus on Small, Large Panels Will Pressure Growth
-
Profire Energy (PFIE) PT, Estimates Raised at Chardan Capital Markets Amid 'Blow-Out' Results
-
Chardan Capital Still Positive on Rockwell Medical (RMTI) Following Q3 Results, Update
-
Streetinsider.com's Hot Lunchtime Reads 11/10: (TWTR) (HIMX) (SVU) (AGU)
-
Himax (HIMX) Q3 Results Should be Firm, But Q4 Guidance Could Come in Light - Chardan Capital
-
ORBCOMM (ORBC) Prices 12.9M Common Offering at $5.60/Share
-
Chardan Capital Boosts Price Target on Rockwell Medical (RMTI) to $27; Sees Triferic Approval by PDUFA Date
-
Chardan Capital Keeps ARIAD (ARIA) at 'Neutral'; Q3 Results Top on Lower R&D Expenses
-
Unusual 11 Mid-Day Movers 11/5: (ESYS) (XWES) (COUP) Higher; (CHUY) (ZAGG) (AMRI) Lower
-
Chardan Capital Reiterates Bullish Stance on YOU On Demand (YOU) Following Xiaomi's Online Video Investment
-
Chardan Comments on Rockwell Medical (RMTI) After Briefing Docs for Triferic’s NDA Posted
-
Chardan Capital Markets Upgrades CEVA Inc. (CEVA) to Neutral
-
Nanosphere, Inc. Announces the Closing of Common Stock Offering

